Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure
- 1 September 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (13) , 1891-1900
- https://doi.org/10.1089/10430340050129503
Abstract
We have investigated the efficacy of a gene transfer strategy based on plasmid DNA electroinjection for the correction of anemia associated with renal failure. An expression plasmid encoding the rat erythropoietin (EPO) cDNA under the control of the CMV promoter as constructed and utilized for this work. Electroinjection of pCMV/rEPO in different rat muscles yielded sustained and long-term EPO production and secretion. The muscle-produced EPO corrected the anemia in five of six nephrectomized rats, used as a model of renal failure. The efficiency of muscle transduction was comparable in rats and mice injected with equivalent amounts of DNA per kilogram of body weight. These results demonstrate that gene electrotransfer can be applied to produce therapeutically significant levels of erythropoietin in chronic renal failure.Keywords
This publication has 43 references indexed in Scilit:
- Continuous Erythropoietin Delivery by Muscle-Targeted Gene Transfer Usingin VivoElectroporationHuman Gene Therapy, 2000
- Induction of Immunity to Antigens Expressed by Recombinant Adeno-Associated Virus Depends on the Route of AdministrationClinical Immunology, 1999
- Safe and Effective Regulation of Hematocrit by Gene Gun Administration of an Erythropoietin-Encoding DNA PlasmidHuman Gene Therapy, 1999
- Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral VectorHuman Gene Therapy, 1997
- Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adenoassociated virus vectorArchives of Dermatology, 1996
- Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokinesImmunity, 1995
- Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA VectorsDNA and Cell Biology, 1993
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal FailureJournal of Clinical Investigation, 1981
- Effect of erythropoietin on anemia of peritoneally dialyzed anephric ratsKidney International, 1979